biomedicale

BONEARMED (BO)

BoneArmed was founded in 2023 in Bologna, operating in the orthopaedic biomedical sector. The startup produces and markets an implantable medical device for treating knee arthritis, applying a completely innovative approach from the perspectives of both cause of arthritic pain and the implanting of the device.

Cellply (BO)

Cellply is a biotechnology company that develops scientific tools automating cell-based functional assays whose aim is to deeply characterize the mode of action of both approved and novel anti-cancer drugs, being able to evaluate the heterogeneity in function of both immune and tumor cells with a single-cell resolution.